| Stage | MMM | % of rev | XPEL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $138M | 100.00% | MMM ×47.78 |
| Gross profit | $2.8B | 42.27% | $62M | 44.63% | XPEL +2.4pp |
| Operating income | $1.6B | 23.66% | $21M | 15.30% | MMM +8.4pp |
| Pre-tax income | $1.7B | 25.36% | $21M | 15.36% | MMM +10.0pp |
| Net income | $1.4B | 21.42% | $17M | 12.12% | MMM +9.3pp |
| Stage | MMM | XPEL | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $138M100.00% | MMM ×47.78 |
| Gross profit | 42.27%$2.8B | 44.63%$62M | XPEL +2.4pp |
| Operating income | 23.66%$1.6B | 15.30%$21M | MMM +8.4pp |
| Pre-tax income | 25.36%$1.7B | 15.36%$21M | MMM +10.0pp |
| Net income |
| 21.42%$1.4B |
| 12.12%$17M |
| MMM +9.3pp |